escitalopram + sulforaphane

Escitalopram + sulforaphane is a combination of two agents, escitalopram and sulforaphane, investigated for potential synergistic effects in the treatment of major depressive disorder. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain by inhibiting its reuptake into presynaptic cells, thereby improving mood and anxiety symptoms[5]. Sulforaphane is an organosulfur compound derived from cruciferous vegetables such as broccoli; it acts primarily as an activator of the Nrf2 pathway, leading to increased antioxidant response and modulation of inflammation[4]. The combination has been studied for enhanced efficacy compared to escitalopram alone in depression management[1].